Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Kimihiko, Takeuchi"'
Autor:
Takanori, Azuma, Kenta, Misaki, Makio, Kusaoi, Yoko, Suzuki, Shinji, Higa, Yoshitaka, Kumon, Tamami, Yoshitama, Taio, Naniwa, Shinsuke, Yamada, Tadashi, Okano, Kimihiko, Takeuchi, Kei, Ikeda, Kenshi, Higami, Masayuki, Inoo, Tetsuji, Sawada, Chonte, Kang, Masatoshi, Hayashi, Yuko, Nagaya, Takafumi, Hagiwara, Eisuke, Shono, Shinkichi, Himeno, Eiichi, Tanaka, Eisuke, Inoue, Yuri, Yoshizawa, Michiaki, Kadode, Hisashi, Yamanaka, Masayoshi, Harigai
Publikováno v:
Modern Rheumatology. 33:271-278
Objectives We performed post-hoc analyses of the ORIGAMI study to investigate whether concomitant methotrexate (MTX) influences the clinical outcomes of abatacept in biologic-naïve patients with rheumatoid arthritis. Methods Enrolled patients (n = 3
Autor:
Takanori Azuma, Kenta Misaki, Makio Kusaoi, Yoko Suzuki, Shinji Higa, Yoshitaka Kumon, Tamami Yoshitama, Taio Naniwa, Shinsuke Yamada, Tadashi Okano, Kimihiko Takeuchi, Kei Ikeda, Kenshi Higami, Masayuki Inoo, Tetsuji Sawada, Chonte Kang, Masatoshi Hayashi, Yuko Nagaya, Takafumi Hagiwara, Eisuke Shono
Publikováno v:
Modern Rheumatology; Mar2023, Vol. 33 Issue 2, p271-278, 8p
Autor:
Yukio Yonemoto, Keio Ayabe, Hirotaka Chikuda, Takahito Suto, Koichi Okamura, Yasuyuki Tamura, Tetsuya Kaneko, Kimihiko Takeuchi, Hideo Sakane
Publikováno v:
Modern Rheumatology. 29:775-781
Objectives: To assess the middle-term outcome of iguratimod (IGU) in rheumatoid arthritis (RA) patients. Methods: Sixty-nine RA patients (14 males and 55 females, mean age of 64.0 years) receiving IGU-containing therapies were enrolled. We divided th
Autor:
Takenobu Iso, Yasuyuki Tamura, Hiroshi Inoue, Koichi Okamura, Kenji Takagishi, Tetsuya Kaneko, Masatoshi Matsushita, Keio Ayabe, Keiko Otsuka, Kimihiko Takeuchi, Chisa Okura, Yukio Yonemoto
Publikováno v:
Modern Rheumatology. 26:24-28
The aim of this study was to compare the efficacy and safety of golimumab (GLM) 50 mg + methotrexate (MTX) combination therapy and GLM 100 mg monotherapy in patients with rheumatoid arthritis (RA).The subjects were 115 RA patients (92 females and 23
Autor:
Yukio Yonemoto, Yoshito Tsushima, Kenji Takagishi, Tetsuya Kaneko, Tsutomu Kobayashi, Chisa Okura, Kimihiko Takeuchi, Koichi Okamura
Publikováno v:
Rheumatology International. 36:109-115
The present retrospective study investigated the relationship between [18F]fluorodeoxyglucose–positron emission tomography (FDG-PET) findings and subsequent progression of joint destruction on plain X-ray. Nineteen rheumatoid arthritis (RA) patient
Autor:
Y. Tamura, Hirotaka Chikuda, Koichi Okamura, Yukio Yonemoto, M. Matsushita, K. Otsuka, K. Ayabe, Tetsuya Kaneko, Masahiro Tachibana, Takahito Suto, Chisa Okura, H. Inoue, M Inoue, Kimihiko Takeuchi
Publikováno v:
Abstracts Accepted for Publication.
Background Iguratimod (IGU) is a small-molecule antirheumatic drug that was developed in Japan and is currently only approved for treatment of rheumatoid arthritis (RA) in Japan and China. IGU suppresses tumor necrosis factor-alpha-induced production
Autor:
Tsutomu Kobayashi, Yukiko Arisaka, Noboru Oriuchi, Yoshito Tsushima, Kimihiko Takeuchi, Yukio Yonemoto, Kenji Takagishi, Koichi Okamura
Publikováno v:
Rheumatology. 51:1484-1491
Objectives. To evaluate whether there is a correlation between the differences in joint uptake of 2-[18F]fluoro-2-deoxy-D-glucose ( 18 F-FDG) and the improvement of clinical findings in RA patients undergoing anti-TNF therapies. Methods. Twenty-two p
Publikováno v:
Modern Rheumatology. 17:67-71
We report the case of a 50-year-old Japanese woman with SAPHO (synovitis-acne-pustulosis-hyperostosis-osteomyelitis) syndrome. Radiographs showed osteosclerosis of the cervical and lumbar vertebrae, as well as osteosclerosis and osteolysis of the rig
Publikováno v:
Modern Rheumatology. 17:67-71
Autor:
Toshihide Hashimoto, Kazuhiro Yoshiuchi, Shyuji Inada, Kenji Shirakura, Naoki Wada, Kimihiko Takeuchi, Masatoshi Matsushita
Publikováno v:
BioPsychoSocial Medicine. 9